Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma.
暂无分享，去创建一个
T. Habuchi | C. Ohyama | M. Saito* | S. Hatakeyama | S. Narita | K. Numakura | Hideo Akashi | S. Kashima | T. Nara | Y. Muto | Mizuki Kobayashi | R. Tabata | Y. Sekine | Satoshi Sato | Hajime Sasagawa | Ryuta Sobu | Ryohei Yamamto